Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity

European Journal of Neuroscience

Volumn 13, Issue 8, 2001, Pages 1529-1536

  Hampson, A J ^a,c   Grimaldi, M ^b,d  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c Cortex Pharmaceuticals Inc ^*  (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Cannabinoid; Cyclic AMP; G protein; Glutamate; Ischemia; Voltage sensitive calcium channels

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ADENYLATE CYCLASE; BUCLADESINE; CALCIUM ION; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CYCLIC AMP; FORSKOLIN; G PROTEIN COUPLED RECEPTOR; GLUTAMIC ACID; RIMONABANT;

AMINO ACID BRAIN LEVEL; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FETUS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REPERFUSION INJURY; TREATMENT OUTCOME;

ANIMALS; BUCLADESINE; CALCIUM; CALCIUM CHANNELS; CANNABINOIDS; CYCLIC AMP; CYCLOHEXANOLS; FORSKOLIN; GLUTAMIC ACID; NEUROTOXINS; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0035004146     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0953-816x.2001.01536.x     Document Type: Article

References (40)

1. Neurotoxicity of glutamate in chick telencephalon neurons: Reduction of toxicity by preincubation with carbachol, but not by the endogenous fatty acid amides anandamide and palmitoylethanolamide [In Process Citation]
2. Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain
3. Delayed treatment with rolipram protects against neuronal damage following global ischemia in rats
4. Cyclic AMP concentrations in rat neocortex and hippocampus during and following incomplete ischemia: Effects of central noradrenergic neurons, prostaglandins, and adenosine
5. CSF cyclic AMP and CSF adenylate kinase in cerebral ischaemic infarction
6. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP
7. Pharmacology of glutamate neurotoxicity in cortical cell culture: Attenuation by NMDA antagonists
8. Aspartate neurotoxicity on cultured cortical neurons
9. Metabotropic glutamate receptor modulation of excitotoxicity in the neostriatum: Role of calcium channels
10. Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process
11. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity
12. Ionic requirements for neurotoxic effects of excitatory amino acid analogues in rat cerebellar slices
13. Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes
14. A new generation of Ca2+ indicators with greatly improved fluorescence properties
15. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission
16. Cannabidiol and (-) Delta9-tetrahydrocannabinol are neuroprotective antioxidants
17. Accumulation of the anandamide precursor, other, N., -acylethanolamine phospholipids in infant rat models of in vivo necrotic, apoptotic neuronal death
18. Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity
19. Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid
20. Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: Application to anandamide
21. Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscle
22. Nonclassical cannabinoid analgetics inhibit adenylate cyclase: Development of a cannabinoid receptor model
23. Effects of T-type, L-type, N-type, P-type, and Q-type calcium channel blockers on stimulus-induced pre- and postsynaptic calcium fluxes in rat hippocampal slices
24. CB1 cannabinoid receptor induction in experimental stroke
25. Selective neuron loss after cerebral ischemia in the rat: Possible role of transmitter glutamate
26. Inhibition of the cAMP signaling cascade via cannabinoid receptors: A putative mechanism of immune modulation by cannabinoid compounds
27. The effect of delta-9-tetrahydrocannabinol on forebrain ischemia in rat
28. Cyclic AMP in the cerebrospinal fluid of patients with recent cerebral infarction
29. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures
30. Glutamate neurotoxicity and stroke
31. Prognostic significance of cerebrospinal fluid cyclic adenosine monophosphate in neonatal asphyxia
32. Ischemia-induced changes in extracellular levels of striatal cyclic AMP: Role of dopamine neurotransmission
33. Synaptic-type acetylcholine receptors raise intracellular calcium levels in neurons by two mechanisms
34. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT
35. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity
36. Dibutyryl cyclic adenosine monophosphate effects in the ischemic-hypoxic cat
37. Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: Involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities
38. Alterations in cyclic AMP generation and G protein subunits following transient ischemia in gerbil hippocampus
39. Enhanced recovery of brain electrical activity by adenosine 3′,5′-cyclic monophosphate following complete global cerebral ischemia in dogs
40. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons